Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
2.
Peptides ; 31(6): 1131-8, 2010 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-20307612

RESUMO

A hypothalamic neuropeptide orexin (hypocretin) is a critical regulator of physiological processes including sleep/wakefulness and feeding. Using organotypic slice culture of rat hypothalamus, we found that exposure to elevated extracellular concentration of K(+) (+10-30 mM) for 24-72h led to a substantial decrease in the number of neurons immunoreactive for orexin and a co-existing neuropeptide dynorphin-A. In contrast, the same treatment affected neither the number of melanin-concentrating hormone-immunoreactive neurons nor the number of total neurons. A substantial decrease of orexin-immunoreactive neurons was also induced by 72h treatment with 1-10 microM veratridine, a Na(+) channel activator. The effect of elevated K(+) was only partially reversible, and that of veratridine was virtually irreversible, although the decrease in orexin immunoreactivity was not associated with signs of cell damage assessed by propidium iodide uptake and Hoechst 33342 nuclear staining. In addition, the level of preproorexin mRNA did not decrease during treatment with elevated K(+) or veratridine. After treatment with elevated K(+) and veratridine, c-Fos immunoreactivity appeared in orexin-immunoreactive neurons but not in melanin-concentrating hormone-immunoreactive neurons, suggesting selective excitation of orexin neurons. However, the amount of orexin released extracellularly was paradoxically decreased by treatment with elevated K(+) and veratridine. Overall, these characteristics of orexin neurons may be taken into consideration to understand the behaviors of these neurons under physiological and pathophysiological conditions.


Assuntos
Hipotálamo/metabolismo , Peptídeos e Proteínas de Sinalização Intracelular/metabolismo , Neuropeptídeos/metabolismo , Potássio/administração & dosagem , Animais , Dinorfinas/metabolismo , Hormônios Hipotalâmicos/metabolismo , Hipotálamo/efeitos dos fármacos , Melaninas/metabolismo , Fármacos Neuromusculares Despolarizantes/farmacologia , Neurônios/efeitos dos fármacos , Neurônios/metabolismo , Orexinas , Hormônios Hipofisários/metabolismo , Proteínas Proto-Oncogênicas c-fos/biossíntese , RNA Mensageiro/metabolismo , Ratos , Ratos Wistar , Veratridina/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA